Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2025

      Kewaunee Scientific Corporation (PRNewsFoto/Kewaunee Scientific Corporation)

      News provided by

      Kewaunee Scientific Corporation

      Dec 11, 2024, 16:04 ET

      Share this article

      Share this article


      STATESVILLE, N.C., Dec. 11, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its second quarter ended October 31, 2024.

      Fiscal Year 2025 Second Quarter Results:

      Sales during the second quarter of fiscal year 2025 were $47,764,000, a decrease of 5.3% compared to sales of $50,436,000 from the prior year's second quarter. Pre-tax earnings for the quarter were $3,931,000 compared to $4,845,000 for the prior year quarter, a decrease of 18.9%. Net earnings were $3,008,000 compared to net earnings of $2,732,000 for the prior year quarter. EBITDA1 for the quarter was $4,883,000 compared to $5,662,000 for the prior year quarter. Diluted earnings per share was $1.01 compared to diluted earnings per share of $0.93 in the prior year quarter.

      The Company's order backlog was at a historically high level of $184.4 million on October 31, 2024, as compared to $146.3 million on October 31, 2023, and $155.6 million on April 30, 2024.

      Domestic Segment - Domestic sales for the quarter were $36,409,000, an increase of 6.5% from sales of $34,185,000 in the prior year quarter. Domestic segment net earnings was $4,524,000 compared to $3,054,000 in the prior year quarter. Domestic segment EBITDA was $6,838,000 compared to $5,230,000 for the prior year quarter. The increase in Domestic sales and earnings was primarily driven by higher product demand.

      International Segment - International sales for the quarter were $11,355,000, a decrease of 30.1% from sales of $16,251,000 in the prior year quarter. International segment net earnings was $356,000 compared to $525,000 in the prior year quarter. International segment EBITDA was $592,000 compared to $1,635,000 for the prior year quarter. The decline in sales is attributable to customer construction site delays in India which pushed out the timing of deliveries.

      Corporate Segment – Corporate segment pre-tax net loss was $2,444,000 for the quarter, as compared to a pre-tax net loss of $1,243,000 in the prior year quarter. Corporate segment EBITDA for the quarter was ($2,547,000) compared to corporate segment EBITDA of ($1,203,000) for the prior year quarter. The change in EBITDA was primarily driven by an increase in professional service and other fees during the quarter related to the acquisition of Nu Aire, Inc., which closed on November 1, 2024, and costs incurred related to Sarbanes-Oxley 404(b) compliance readiness.

      Total cash on hand on October 31, 2024 was $29,664,000, as compared to $25,938,000 on April 30, 2024. Working capital was $59,965,000, as compared to $52,144,000 at the end of the second quarter last year and $56,037,000 on April 30, 2024.

      The Company had short-term debt of $805,000 as of October 31, 2024, as compared to $3,099,000 on April 30, 2024. Long-term debt was $28,047,000 on October 31, 2024, as compared to $28,479,000 on April 30, 2024. The building lease from the Company's December 2021 sale-leaseback transaction accounts for $27,782,000 of the long-term debt on October 31, 2024 and $28,133,000 of the long-term debt on April 30, 2024. Long-term debt, net of the sale-leaseback transaction, was $265,000 on October 31, 2024 as compared to $346,000 on April 30, 2024. The Company's debt-to-equity ratio on October 31, 2024 was 0.59-to-1, as compared to 0.70-to-1 on April 30, 2024. The Company's debt-to-equity ratio, net of the sale-leaseback transaction, on October 31, 2024 was 0.14-to-1, as compared to 0.20-to-1 on April 30, 2024.

      "Our financial performance for the second quarter of fiscal year 2025 was strong," said Thomas D. Hull III, Kewaunee's President and Chief Executive Officer. "Domestic segment operating performance improved compared to last year's second quarter as a result of higher product demand, highlighting our continued health and advantage in the market. As discussed during the first quarter of fiscal year 2025, customer construction site delays in India on multiple projects continue to impact our ability to ship products and deliver services, leading to a decrease in sales and earnings when compared to the prior year second quarter."

      "Looking ahead, our backlog remains very healthy, demonstrating the continued vitality and investment in the markets in which Kewaunee participates and the success both Kewaunee and our channel partners continue to achieve in the marketplace. The strength of Kewaunee's backlog positions the company well to deliver another strong year for our fiscal year."

      "Additionally, on November 1, 2024, Kewaunee announced the acquisition of Nu Aire, Inc.," Hull continued. "Nu Aire is renowned for its manufacturing of robust containment solutions, such as biological safety cabinets, airflow products, and more, which serve a diverse range of industries. While not reflected in our second quarter fiscal year 2025 results, Nu Aire will be included going forward, beginning with our third quarter fiscal year 2025 results. It is worth noting the company incurred expenses related to the acquisition of $2.3 million in the current fiscal year, which are outlined in the attached exhibits."

      "The acquisition of Nu Aire presents a unique opportunity for Kewaunee to expand its capabilities, allowing the combined organization to better meet the diverse needs of end-users in laboratory furnishings and, through Nu Aire's established distribution partners, reach regions where Kewaunee has not previously had a presence. This move accelerates the Company's vision of becoming the market leader in the design and manufacturing of laboratory furniture and technical products essential for outfitting the laboratories of tomorrow."

      1 EBITDA is a non-GAAP financial measure. See the table below for a reconciliation of EBITDA and segment EBITDA to net earnings (loss), the most directly comparable GAAP measure.

      EBITDA, Segment EBITDA, Adjusted EBITDA, and Adjusted Segment EBITDA Reconciliation

      (Unaudited)

      ($ in thousands)

      Quarter Ended October 31, 2023


      Domestic


      International


      Corporate


      Consolidated

      Net Earnings (Loss)


      $                  3,054


      $                     525


      $                   (847)


      $                  2,732

      Add/(Less):









      Interest Expense


      323


      35


      14


      372

      Interest Income


      —


      (205)


      (22)


      (227)

      Income Taxes


      1,232


      1,179


      (396)


      2,015

      Depreciation and Amortization


      621


      101


      48


      770

      EBITDA


      $                  5,230


      $                  1,635


      $                (1,203)


      $                  5,662










      Quarter Ended October 31, 2024


      Domestic


      International


      Corporate


      Consolidated

      Net Earnings (Loss)


      $                  4,524


      $                     356


      $                (1,872)


      $                  3,008

      Add/(Less):









      Interest Expense


      413


      19


      10


      442

      Interest Income


      —


      (133)


      (156)


      (289)

      Income Taxes


      1,241


      247


      (572)


      916

      Depreciation and Amortization


      660


      103


      43


      806

      EBITDA


      $                  6,838


      $                     592


      $                (2,547)


      $                  4,883

      Professional & Other Fees


      —


      —


                         1,5402


      1,540

      Adjusted EBITDA


      $                  6,838


      $                     592


      $                (1,007)


      $                  6,423










      Year to Date October 31, 2023


      Domestic


      International


      Corporate


      Consolidated

      Net Earnings (Loss)


      $                  5,765


      $                     994


      $                (1,553)


      $                  5,206

      Add/(Less):









      Interest Expense


      703


      71


      28


      802

      Interest Income


      —


      (418)


      (23)


      (441)

      Income Taxes


      2,145


      1,461


      (694)


      2,912

      Depreciation and Amortization


      1,195


      197


      96


      1,488

      EBITDA


      $                  9,808


      $                  2,305


      $                (2,146)


      $                  9,967










      Year to Date October 31, 2024


      Domestic


      International


      Corporate


      Consolidated

      Net Earnings (Loss)


      $                  7,395


      $                     819


      $                (3,013)


      $                  5,201

      Add/(Less):









      Interest Expense


      854


      40


      20


      914

      Interest Income


      —


      (307)


      (329)


      (636)

      Income Taxes


      2,005


      526


      (1,423)


      1,108

      Depreciation and Amortization


      1,322


      210


      89


      1,621

      EBITDA


      $                11,576


      $                  1,288


      $                (4,656)


      $                  8,208

      Professional & Other Fees


      —


      —


                         2,2703


      2,270

      Adjusted EBITDA


      $                11,576


      $                  1,288


      $                (2,386)


      $                10,478

      ______________________________

      2 Professional and other fees  incurred during the three months ended October 31, 2024 related to the Company's acquisition of Nu Aire, Inc. ("Nu Aire"), which closed on November 1, 2024

      3 Professional and other fees incurred during the six months ended October 31, 2024 related to the Company's acquisition of Nu Aire

      Adjusted Consolidated Statement of Operations Reconciliation

      (Unaudited)

      ($ in thousands, except per share amounts)


      Three Months Ended October 31,


      As Reported
      2024


      Professional
      & Other Fees


      Adjusted
      2024


      2023

      Net sales

      $      47,764


      $              —


      $       47,764


      $      50,436

      Cost of products sold

      33,812


      —


      33,812


      36,968

      Gross profit

      13,952


      —


      13,952


      13,468

      Operating expenses

      9,518


                1,2164


      8,302


      8,359

      Operating profit

      4,434


      1,216


      5,650


      5,109

      Pension expense

      —


      —


      —


      (40)

      Other (expense) income, net

      (61)


                   3245


      263


      148

      Interest expense

      (442)


      —


      (442)


      (372)

      Profit before income taxes

      3,931


      1,540


      5,471


      4,845

      Income tax expense

      916


                   3516


      1,267


      2,015

      Net earnings

      3,015


      1,189


      4,204


      2,830

      Less: Net earnings attributable to the non-controlling interest

      7


      —


      7


      98

      Net earnings attributable to Kewaunee Scientific Corporation

      $         3,008


      $         1,189


      $         4,197


      $         2,732









      Net earnings per share attributable to Kewaunee Scientific Corporation stockholders








      Basic

      $           1.05


      $           0.41


      $           1.46


      $           0.94

      Diluted

      $           1.01


      $           0.40


      $           1.41


      $           0.93



      Six Months Ended October 31,


      As Reported
      2024


      Professional &
      Other Fees


      Adjusted
      2024


      2023

      Net sales

      $      96,157


      $              —


      $       96,157


      $    100,275

      Cost of products sold

      69,717


      —


      69,717


      74,893

      Gross profit

      26,440


      —


      26,440


      25,382

      Operating expenses

      19,431


                1,9467


      17,485


      16,465

      Operating profit

      7,009


      1,946


      8,955


      8,917

      Pension expense

      —


      —


      —


      (81)

      Other income, net

      266


                   3248


      590


      223

      Interest expense

      (914)


      —


      (914)


      (802)

      Profit before income taxes

      6,361


      2,270


      8,631


      8,257

      Income tax expense

      1,108


                   5189


      1,626


      2,912

      Net earnings

      5,253


      1,752


      7,005


      5,345

      Less: Net earnings attributable to the non-controlling interest

      52


      —


      52


      139

      Net earnings attributable to Kewaunee Scientific Corporation

      $         5,201


      $         1,752


      $         6,953


      $         5,206









      Net earnings per share attributable to Kewaunee Scientific Corporation stockholders








      Basic

      $           1.82


      $            0.61


      $            2.43


      $           1.81

      Diluted

      $           1.75


      $            0.59


      $            2.34


      $           1.79

      ______________________________

      4 Professional fees incurred during the three months ended October 31, 2024 related to the Company's acquisition of Nu Aire

      5 Cost incurred related to the early termination of the Company's Revolving Credit Facility

      6 Estimated tax impact of professional and other fees incurred during the three months ended October 31, 2024 related to the Company's acquisition of Nu Aire

      7 Professional fees incurred during the six months ended October 31, 2024 related to the Company's acquisition of Nu Aire

      8 Cost incurred related to the early termination of the Company's Revolving Credit Facility

      9 Estimated tax impact of professional and other fees incurred during the six months ended October 31, 2024 related to the Company's acquisition of Nu Aire

      About Non-GAAP Measures 

      The Company includes non-GAAP financial measures such as adjusted net earnings and adjusted net earnings per share, in the information provided with this press release as supplemental information relating to its operating results. Adjusted net earnings represents GAAP net earnings adjusted for professional and other fees related to the acquisition of Nu Aire, Inc. and the corresponding tax impact. This financial information is not in accordance with, or an alternative for, GAAP-compliant financial information and may be different from the operating or non-GAAP financial information used by other companies. The Company believes that this presentation of adjusted net earnings and adjusted net earnings per share provides useful information to investors regarding certain additional financial and business trends relating to its financial condition and results of operations.

      EBITDA and Segment EBITDA are calculated as net earnings (loss), less interest expense and interest income, income taxes, depreciation, and amortization. Adjusted EBITDA and Adjusted Segment EBITDA are calculated as EBITDA or Segment EBITDA less the impact of the professional and other fees related to the Company's acquisition of Nu Aire, Inc., as discussed in more detail above. We believe EBITDA, Segment EBITDA, Adjusted EBITDA, and Adjusted Segment EBITDA allow management and investors to compare our performance to other companies on a consistent basis without regard to depreciation and amortization or the professional fees not related to our core business incurred during the current period, which can vary significantly between companies depending upon many factors. EBITDA, Segment EBITDA, Adjusted EBITDA, and Adjusted Segment EBITDA are not calculations based upon generally accepted accounting principles, and the method for calculating EBITDA, Segment EBITDA, Adjusted EBITDA, and Adjusted Segment EBITDA can vary among companies. The amounts included in the EBITDA, Segment EBITDA, Adjusted EBITDA, and Adjusted Segment EBITDA calculations, however, are derived from amounts included in the historical consolidated statements of operations. EBITDA, Segment EBITDA, Adjusted EBITDA, and Adjusted Segment EBITDA should not be considered as alternatives to net earnings (loss) or operating earnings (loss) as an indicator of the Company's operating performance, or as an alternative to operating cash flows as a measure of liquidity.

      About Nu Aire

      Founded in 1971 and based in Minneapolis, the Company is a leading manufacturer of equipment for a diverse range of laboratory and pharmacy environments. Nu Aire is the North American market share leader in biological safety cabinets and other airflow products and also offers a complete line of CO2 incubators, ultralow freezers, animal handling equipment, pharmacy compounding isolators, and parts and accessories. Nu Aire's equipment is required for safety and quality in every type of laboratory: life sciences research, clinical, hospital, biotech and pharmaceutical R&D, academia, food and beverage, industrial and more. Nu Aire's website is located at http://www.nuaire.com/. 

      About Kewaunee Scientific

      Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.

      The Company's corporate headquarters are located in Statesville, North Carolina. Sales offices are located in the United States, India, Saudi Arabia, and Singapore. Three manufacturing facilities are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets. Kewaunee Scientific's website is located at http://www.kewaunee.com.  

      This press release contains statements that the Company believes to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements regarding the Company's future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "predict," "believe" and similar words, expressions and variations of these words and expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other important factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. Such factors, risks, uncertainties and assumptions include, but are not limited to: our ability to realize the benefits anticipated as a result of the Nu Aire acquisition; competitive and general economic conditions, including disruptions from government mandates, both domestically and internationally, as well as supplier constraints and other supply disruptions; changes in customer demands; technological changes in our operations or in our industry; dependence on customers' required delivery schedules; risks related to fluctuations in the Company's operating results from quarter to quarter; risks related to international operations, including foreign currency fluctuations; changes in the legal and regulatory environment; changes in raw materials and commodity costs; acts of terrorism, war, governmental action, and natural disasters and other Force Majeure events. The cautionary statements made pursuant to the Reform Act herein and elsewhere by us should not be construed as exhaustive. We cannot always predict what factors would cause actual results to differ materially from those indicated by the forward-looking statements. Over time, our actual results, performance, or achievements will likely differ from the anticipated results, performance or achievements that are expressed or implied by our forward-looking statements, and such difference might be significant and harmful to our stockholders' interest. Many important factors that could cause such a difference are described under the caption "Risk Factors," in Item 1A of our Annual Report on Form 10-K for the fiscal year ended April 30, 2024, which you should review carefully, and in our subsequent quarterly reports on Form 10-Q and current reports on Form 8-K. These reports are available on our investor relations website at www.kewaunee.com and on the SEC website at www.sec.gov. These forward-looking statements speak only as of the date of this document. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.

      Kewaunee Scientific Corporation

      Condensed Consolidated Statements of Operations

      (Unaudited)

      ($ and shares in thousands, except per share amounts)


      Three Months Ended

      October 31,


      Six Months Ended

      October 31,


      2024


      2023


      2024


      2023

      Net sales

      $       47,764


      $       50,436


      $       96,157


      $     100,275

      Cost of products sold

      33,812


      36,968


      69,717


      74,893

      Gross profit

      13,952


      13,468


      26,440


      25,382

      Operating expenses

      9,518


      8,359


      19,431


      16,465

      Operating profit

      4,434


      5,109


      7,009


      8,917

      Pension expense

      —


      (40)


      —


      (81)

      Other (expense) income, net

      (61)


      148


      266


      223

      Interest expense

      (442)


      (372)


      (914)


      (802)

      Profit before income taxes

      3,931


      4,845


      6,361


      8,257

      Income tax expense

      916


      2,015


      1,108


      2,912

      Net earnings

      3,015


      2,830


      5,253


      5,345

      Less: Net earnings attributable to the non-controlling interest

      7


      98


      52


      139

      Net earnings attributable to Kewaunee Scientific Corporation

      $          3,008


      $          2,732


      $          5,201


      $          5,206









      Net earnings per share attributable to Kewaunee Scientific Corporation stockholders








      Basic

      $            1.05


      $            0.94


      $            1.82


      $            1.81

      Diluted

      $            1.01


      $            0.93


      $            1.75


      $            1.79

      Weighted average number of common shares outstanding








      Basic

      2,872


      2,903


      2,861


      2,882

      Diluted

      2,974


      2,931


      2,971


      2,908

      Kewaunee Scientific Corporation

      Condensed Consolidated Balance Sheets

      ($ in thousands)


      October 31,
      2024


      April 30, 2024


      (Unaudited)



      Assets




      Cash and cash equivalents

      $           25,963


      $           23,267

      Restricted cash

      3,701


      2,671

      Receivables, less allowances

      41,885


      45,064

      Inventories

      18,659


      20,679

      Prepaid expenses and other current assets

      6,228


      5,136

      Total Current Assets

      96,436


      96,817

      Net Property, Plant and Equipment

      16,990


      17,649

      Right of use assets

      6,941


      7,454

      Deferred income taxes

      8,305


      7,401

      Other assets

      5,806


      5,445

      Total Assets

      $         134,478


      $         134,766





      Liabilities and Stockholders' Equity




      Short-term borrowings

      $                805


      $             3,099

      Current portion of lease obligations

      2,221


      2,234

      Current portion of financing liability

      750


      713

      Accounts payable

      21,458


      23,262

      Other current liabilities

      11,237


      11,472

      Total Current Liabilities

      36,471


      40,780

      Long-term portion of lease obligations

      5,191


      5,669

      Long-term portion of financing liability

      27,032


      27,420

      Other non-current liabilities

      5,127


      4,688

      Total Liabilities

      73,821


      78,557

      Kewaunee Scientific Corporation Equity

      59,328


      54,760

      Non-controlling interest

      1,329


      1,449

      Total Stockholders' Equity

      60,657


      56,209

      Total Liabilities and Stockholders' Equity

      $         134,478


      $         134,766

      Contact:         

      Donald T. Gardner III


      704/871-3274

      SOURCE Kewaunee Scientific Corporation

      Modal title

      Also from this source

      Kewaunee Scientific Announces Agreement to Acquire Nycom, Inc.

      Kewaunee Scientific Announces Agreement to Acquire Nycom, Inc.

      Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that it has entered into a definitive agreement to acquire Nycom, Inc. ("Nycom"), the...

      Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2027

      Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2027

      Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its first quarter ended July 31, 2026. Fiscal Year 2027 First Quarter...

      More Releases From This Source

      Explore

      Medical Equipment

      Medical Equipment

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Earnings

      Earnings

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.